HEADER BIOSYNTHETIC PROTEIN 17-AUG-22 8E4A TITLE PSEUDOMONAS LPXC IN COMPLEX WITH LPC-233 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UDP-3-O-ACYL-GLCNAC DEACETYLASE,UDP-3-O-[R-3- COMPND 5 HYDROXYMYRISTOYL]-N-ACETYLGLUCOSAMINE DEACETYLASE; COMPND 6 EC: 3.5.1.108; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: LPXC; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LPXC, LIPID A, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.NAJEEB,P.ZHOU REVDAT 1 23-AUG-23 8E4A 0 JRNL AUTH J.ZHAO,C.S.COCHRANE,J.NAJEEB,D.GOODEN,C.SCIANDRA,P.FAN, JRNL AUTH 2 N.LEMAITRE,K.NEWNS,R.A.NICHOLAS,Z.GUAN,J.T.THADEN, JRNL AUTH 3 V.G.FOWLER JR.,I.SPASOJEVIC,F.SEBBANE,E.J.TOONE,C.DUNCAN, JRNL AUTH 4 R.GAMMANS,P.ZHOU JRNL TITL PRECLINICAL SAFETY AND EFFICACY CHARACTERIZATION OF AN LPXC JRNL TITL 2 INHIBITOR AGAINST GRAM-NEGATIVE PATHOGENS. JRNL REF SCI TRANSL MED V. 15 F5668 2023 JRNL REFN ESSN 1946-6242 JRNL PMID 37556556 JRNL DOI 10.1126/SCITRANSLMED.ADF5668 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 17692 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 885 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.0400 - 3.7000 0.87 2726 144 0.1446 0.1588 REMARK 3 2 3.7000 - 2.9300 0.91 2794 147 0.1555 0.1815 REMARK 3 3 2.9300 - 2.5600 0.92 2812 148 0.1793 0.2262 REMARK 3 4 2.5600 - 2.3300 0.92 2829 149 0.1901 0.2330 REMARK 3 5 2.3300 - 2.1600 0.92 2823 149 0.1919 0.2389 REMARK 3 6 2.1600 - 2.0340 0.93 2823 148 0.2207 0.2720 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.217 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.014 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2420 REMARK 3 ANGLE : 0.503 3286 REMARK 3 CHIRALITY : 0.044 375 REMARK 3 PLANARITY : 0.004 431 REMARK 3 DIHEDRAL : 8.700 341 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 10.0593 4.8599 76.3989 REMARK 3 T TENSOR REMARK 3 T11: 0.0507 T22: 0.0489 REMARK 3 T33: 0.0493 T12: 0.0043 REMARK 3 T13: 0.0043 T23: 0.0021 REMARK 3 L TENSOR REMARK 3 L11: 0.2364 L22: 0.1467 REMARK 3 L33: 0.0962 L12: 0.0175 REMARK 3 L13: 0.1470 L23: 0.0150 REMARK 3 S TENSOR REMARK 3 S11: 0.0185 S12: 0.0041 S13: 0.0051 REMARK 3 S21: 0.0066 S22: -0.0039 S23: 0.0219 REMARK 3 S31: -0.0145 S32: 0.0028 S33: 0.0004 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8E4A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267787. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-AUG-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17695 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.034 REMARK 200 RESOLUTION RANGE LOW (A) : 46.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.10420 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3P3E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 MM PROTEIN, 0.6 MM LPC-233, 12.5 REMARK 280 MM HEPES (PH 7.1), 25 MM NACL, 1 MM TCEP, 0.085 M SODIUM ACETATE, REMARK 280 0.0425 M TRIS HCL PH 8.5, 12.75% PEG 4000, 7.5% GLYCEROL, 5 MM REMARK 280 CALCIUM CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.22500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 166 CB CG CD NE CZ NH1 NH2 REMARK 470 ARG A 168 CB CG CD NE CZ NH1 NH2 REMARK 470 THR A 169 CB OG1 CG2 REMARK 470 ARG A 195 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 198 CG CD OE1 OE2 REMARK 470 SER A 202 OG REMARK 470 GLU A 287 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 62 -61.97 -100.35 REMARK 500 MET A 62 -61.84 -100.35 REMARK 500 MET A 103 -119.83 58.38 REMARK 500 ASP A 161 50.40 -94.87 REMARK 500 GLN A 170 52.75 -110.64 REMARK 500 SER A 178 -33.22 -135.25 REMARK 500 ASP A 218 -157.01 -88.88 REMARK 500 ASN A 220 -34.13 -142.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 669 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH A 670 DISTANCE = 6.78 ANGSTROMS REMARK 525 HOH A 671 DISTANCE = 7.27 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 78 NE2 REMARK 620 2 HIS A 237 NE2 83.9 REMARK 620 3 ASP A 241 OD1 88.3 87.5 REMARK 620 4 ASP A 241 OD2 140.6 89.7 52.5 REMARK 620 5 UFX A 302 O04 121.1 149.5 108.8 81.1 REMARK 620 6 UFX A 302 O01 134.6 83.8 134.4 82.7 66.3 REMARK 620 7 HOH A 476 O 79.1 111.5 155.6 138.4 62.3 65.5 REMARK 620 N 1 2 3 4 5 6 DBREF1 8E4A A 1 299 UNP A0A072ZC86_PSEAI DBREF2 8E4A A A0A072ZC86 1 299 SEQADV 8E4A SER A 40 UNP A0A072ZC8 CYS 40 ENGINEERED MUTATION SEQRES 1 A 299 MET ILE LYS GLN ARG THR LEU LYS ASN ILE ILE ARG ALA SEQRES 2 A 299 THR GLY VAL GLY LEU HIS SER GLY GLU LYS VAL TYR LEU SEQRES 3 A 299 THR LEU LYS PRO ALA PRO VAL ASP THR GLY ILE VAL PHE SEQRES 4 A 299 SER ARG THR ASP LEU ASP PRO VAL VAL GLU ILE PRO ALA SEQRES 5 A 299 ARG ALA GLU ASN VAL GLY GLU THR THR MET SER THR THR SEQRES 6 A 299 LEU VAL LYS GLY ASP VAL LYS VAL ASP THR VAL GLU HIS SEQRES 7 A 299 LEU LEU SER ALA MET ALA GLY LEU GLY ILE ASP ASN ALA SEQRES 8 A 299 TYR VAL GLU LEU SER ALA SER GLU VAL PRO ILE MET ASP SEQRES 9 A 299 GLY SER ALA GLY PRO PHE VAL PHE LEU ILE GLN SER ALA SEQRES 10 A 299 GLY LEU GLN GLU GLN GLU ALA ALA LYS LYS PHE ILE ARG SEQRES 11 A 299 ILE LYS ARG GLU VAL SER VAL GLU GLU GLY ASP LYS ARG SEQRES 12 A 299 ALA VAL PHE VAL PRO PHE ASP GLY PHE LYS VAL SER PHE SEQRES 13 A 299 GLU ILE ASP PHE ASP HIS PRO VAL PHE ARG GLY ARG THR SEQRES 14 A 299 GLN GLN ALA SER VAL ASP PHE SER SER THR SER PHE VAL SEQRES 15 A 299 LYS GLU VAL SER ARG ALA ARG THR PHE GLY PHE MET ARG SEQRES 16 A 299 ASP ILE GLU TYR LEU ARG SER GLN ASN LEU ALA LEU GLY SEQRES 17 A 299 GLY SER VAL GLU ASN ALA ILE VAL VAL ASP GLU ASN ARG SEQRES 18 A 299 VAL LEU ASN GLU ASP GLY LEU ARG TYR GLU ASP GLU PHE SEQRES 19 A 299 VAL LYS HIS LYS ILE LEU ASP ALA ILE GLY ASP LEU TYR SEQRES 20 A 299 LEU LEU GLY ASN SER LEU ILE GLY GLU PHE ARG GLY PHE SEQRES 21 A 299 LYS SER GLY HIS ALA LEU ASN ASN GLN LEU LEU ARG THR SEQRES 22 A 299 LEU ILE ALA ASP LYS ASP ALA TRP GLU VAL VAL THR PHE SEQRES 23 A 299 GLU ASP ALA ARG THR ALA PRO ILE SER TYR MET ARG PRO HET ZN A 301 1 HET UFX A 302 27 HETNAM ZN ZINC ION HETNAM UFX 4-(4-CYCLOPROPYLBUTA-1,3-DIYN-1-YL)-N-[(2S,3S)-4,4- HETNAM 2 UFX DIFLUORO-3-HYDROXY-1-(HYDROXYAMINO)-3-METHYL-1- HETNAM 3 UFX OXOBUTAN-2-YL]BENZAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 UFX C19 H18 F2 N2 O4 FORMUL 4 HOH *271(H2 O) HELIX 1 AA1 ARG A 53 VAL A 57 5 5 HELIX 2 AA2 VAL A 76 LEU A 86 1 11 HELIX 3 AA3 ALA A 107 GLY A 118 1 12 HELIX 4 AA4 HIS A 162 ARG A 166 5 5 HELIX 5 AA5 SER A 180 VAL A 185 1 6 HELIX 6 AA6 MET A 194 GLN A 203 1 10 HELIX 7 AA7 ASP A 232 TYR A 247 1 16 HELIX 8 AA8 LEU A 248 GLY A 250 5 3 HELIX 9 AA9 GLY A 263 ASP A 277 1 15 HELIX 10 AB1 ASP A 288 ALA A 292 5 5 SHEET 1 AA1 2 LYS A 3 LEU A 7 0 SHEET 2 AA1 2 LEU A 119 ALA A 125 -1 O GLN A 122 N GLN A 4 SHEET 1 AA2 5 ILE A 11 VAL A 16 0 SHEET 2 AA2 5 LYS A 23 PRO A 30 -1 O LEU A 26 N ALA A 13 SHEET 3 AA2 5 ALA A 91 LEU A 95 -1 O GLU A 94 N THR A 27 SHEET 4 AA2 5 ILE A 37 ARG A 41 1 N VAL A 38 O VAL A 93 SHEET 5 AA2 5 VAL A 48 PRO A 51 -1 O ILE A 50 N PHE A 39 SHEET 1 AA3 2 THR A 65 LYS A 68 0 SHEET 2 AA3 2 VAL A 71 ASP A 74 -1 O VAL A 73 N LEU A 66 SHEET 1 AA4 5 VAL A 135 GLU A 139 0 SHEET 2 AA4 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 AA4 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 AA4 5 PHE A 152 GLU A 157 1 N SER A 155 O GLY A 259 SHEET 5 AA4 5 GLN A 171 ASP A 175 -1 O VAL A 174 N VAL A 154 SHEET 1 AA5 5 VAL A 135 GLU A 139 0 SHEET 2 AA5 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 AA5 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 AA5 5 PHE A 128 ILE A 131 1 N ILE A 129 O ILE A 254 SHEET 5 AA5 5 TRP A 281 VAL A 284 -1 O GLU A 282 N ARG A 130 SHEET 1 AA6 2 PHE A 191 PHE A 193 0 SHEET 2 AA6 2 ILE A 215 VAL A 217 1 O ILE A 215 N GLY A 192 LINK NE2 HIS A 78 ZN ZN A 301 1555 1555 2.30 LINK NE2 HIS A 237 ZN ZN A 301 1555 1555 2.30 LINK OD1 ASP A 241 ZN ZN A 301 1555 1555 2.38 LINK OD2 ASP A 241 ZN ZN A 301 1555 1555 2.56 LINK ZN ZN A 301 O04 UFX A 302 1555 1555 2.62 LINK ZN ZN A 301 O01 UFX A 302 1555 1555 2.39 LINK ZN ZN A 301 O HOH A 476 1555 1555 2.66 CISPEP 1 ASP A 45 PRO A 46 0 1.76 CRYST1 35.970 66.450 63.840 90.00 90.68 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027801 0.000000 0.000328 0.00000 SCALE2 0.000000 0.015049 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015665 0.00000